Analyst Ratings for LifeMD
Portfolio Pulse from Benzinga Insights
LifeMD (NASDAQ:LFMD) has received 4 bullish ratings from analysts in the last quarter, with an average 12-month price target of $7.75, up 10.71% from the previous average price target of $7.00.

October 02, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LifeMD has received positive analyst ratings, which could potentially boost its stock price in the short term.
Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, LifeMD has received 4 bullish ratings in the last quarter, which indicates a positive outlook for the company. This could potentially lead to an increase in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100